List of Excipients in API eprosartan mesylate and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing eprosartan mesylate and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | TEVETEN HCT | eprosartan mesylate and hydrochlorothiazide | 54868-5281 | CELLULOSE, MICROCRYSTALLINE | |
| Physicians Total Care Inc | TEVETEN HCT | eprosartan mesylate and hydrochlorothiazide | 54868-5281 | CROSPOVIDONE | |
| Physicians Total Care Inc | TEVETEN HCT | eprosartan mesylate and hydrochlorothiazide | 54868-5281 | FERRIC OXIDE YELLOW | |
| Physicians Total Care Inc | TEVETEN HCT | eprosartan mesylate and hydrochlorothiazide | 54868-5281 | FERROSOFERRIC OXIDE | |
| Physicians Total Care Inc | TEVETEN HCT | eprosartan mesylate and hydrochlorothiazide | 54868-5281 | LACTOSE MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for eprosartan mesylate and hydrochlorothiazide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
eprosartan mesylate and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
eprosartan mesylate and hydrochlorothiazide drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
eprosartan mesylate and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
eprosartan mesylate and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
eprosartan mesylate and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
eprosartan mesylate and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
eprosartan mesylate and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
eprosartan mesylate and hydrochlorothiazide drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
eprosartan mesylate and hydrochlorothiazide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
eprosartan mesylate and hydrochlorothiazide drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
eprosartan mesylate and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
eprosartan mesylate and hydrochlorothiazide drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | eprosartan mesylate and hydrochlorothiazide | 54868-5281 |
| >Company | >Ingredient | >NDC |
eprosartan mesylate and hydrochlorothiazide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
